Related Experiment Video
Updated: Aug 29, 2026

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
Published on: January 24, 2025
White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2
Peter C Tong1, Ka-Fai Lee, Wing-Yee So
1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T., Hong Kong. ptong@cuhk.edu.hk
Insights
Elevated white blood cell (WBC) counts, even within the normal range, are linked to increased vascular complications in type 2 diabetes patients. This suggests chronic inflammation plays a role in diabetes-related complications.
Area of Science:
- Endocrinology
- Cardiology
- Inflammation Research
Background:
- Raised white blood cell (WBC) count is associated with coronary heart disease and metabolic syndrome.
- The link between WBC count and vascular complications in diabetes remains under-explored.
Purpose of the Study:
- To investigate the association between WBC count and macrovascular and microvascular complications in patients with type 2 diabetes.
Main Methods:
- Cross-sectional cohort study of 3,776 patients with type 2 diabetes.
- Comprehensive assessment of complications and risk factors using the European DiabCare protocol.
- Measurement of metabolic profiles, including complete blood count and urinary albumin excretion.
Main Results:
- Higher WBC counts correlated with adverse metabolic profiles (higher BMI, HbA1c, blood pressure, lipids, albuminuria; lower HDL).
- Prevalence of macro- and microvascular complications increased with WBC count in a dose-dependent manner.
- Each 1 x 10(9)/l increment in WBC count was associated with a significant increase in macro- (15.8%) and microvascular (12.3%) complications.
Conclusions:
- Elevated WBC count, even within the normal range, is significantly associated with macro- and microvascular complications in type 2 diabetes.
- Chronic inflammation, indicated by higher WBC count, may be a key factor in the development of vascular complications in diabetes.
Objectives:
There are close associations among raised white blood cell (WBC) count, coronary heart disease, and metabolic syndrome in the general population. The association between WBC count and vascular complications of diabetes has not been explored. We carried out a cross-sectional cohort study to determine the association between WBC count and the presence of macro- and microvascular complications in type 2 diabetes.
Research Design And Methods:
In this study, 3,776 patients with type 2 diabetes and normal WBC count (3.5-12.5 x 10(9)/l) underwent a comprehensive assessment of complications and cardiovascular risk factors based on the European DiabCare protocol. Demographic and anthropometric parameters were recorded. Metabolic profiles, including complete blood picture and urinary albumin excretion, were measured.
Results:
Patients with higher WBC counts (categorized into quintiles) had adverse metabolic profiles as evidenced by higher blood pressure, BMI, HbA(1c), fasting plasma glucose, LDL cholesterol, triglycerides, and urinary albumin excretion, but lower HDL cholesterol (all P <0.001 for trend). The prevalence of macro- and microvascular complications increased in a dosage-related manner with WBC count. After adjustments for smoking and other known cardiovascular risk factors, a 1-unit (1 x 10(9)/l) increment of WBC count was associated with a 15.8% (95% CI 9.3-22.6; P < 0.001) and 12.3% increase (5.8-19.1; P < 0.001) in the prevalence of macro- and microvascular complications, respectively.
Conclusions:
Elevated WBC count, even within the normal range, is associated with both macro- and microvascular complications in type 2 diabetes. Chronic inflammation, as indicated by a higher WBC count, may play a linkage role in the development of macro- and microvascular complications in diabetes.
Related Concept Videos
Diabetic Retinopathy
Complications of Diabetes Mellitus
Diabetes: Symptoms, Diagnosis, and Complications
Diabetic Nephropathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology